Schaeffer's Street Stories: After an Upgrade, Pfizer Inc. is Little Changed

* Reuters is not responsible for the content in this press release.

Mon Jan 12, 2009 2:17pm EST 

CINCINNATI--(Business Wire)--
Some bullish news hit the Street today for blue chip pharmaceutical concern
Pfizer Inc. (NYSE: PFE). Goldman Sachs removed PFE from its Americas Sell List.
The brokerage firm said, "Pressure is mounting on management to do something big
and soon." 

"Almost regardless of what precisely this action is, we believe the stock would
respond positively to a sign of positive, dramatic change at Pfizer," Goldman
analyst Jami Rubin said in a note to investors. The firm upgraded the stock from
"sell" to "neutral." 

To continue reading this article, click here:
http://www.schaeffersresearch.com/commentary/content/after+an+upgrade+pfizer+inc+is+little+changed/observations.aspx?click=home&ID=90439





Schaeffer's Investment Research
Colleen S. King, 513-589-3800
(cking@sir-inc.com)


Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.